Elite Pharmaceuticals Inc ELTP:OTCQB

RT Quote | Exchange | USD
Last | 3:56 PM EST
0.034quote price arrow up+0.0009 (+2.72%)
Volume
1,027,744
52 week range
0.03 - 0.09
Loading...
  • Open0.0312
  • Day High0.0368
  • Day Low0.0312
  • Prev Close0.0331
  • 52 Week High0.09
  • 52 Week High Date02/16/21
  • 52 Week Low0.03
  • 52 Week Low Date11/29/21

Key Stats

  • Market Cap34.38M
  • Shares Out1.011B
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.76
  • YTD % Change-32.89

KEY STATS

  • Open0.0312
  • Day High0.0368
  • Day Low0.0312
  • Prev Close0.0331
  • 52 Week High0.09
  • 52 Week High Date02/16/21
  • 52 Week Low0.03
  • 52 Week Low Date11/29/21
  • Market Cap34.38M
  • Shares Out1.011B
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.76
  • YTD % Change-32.89

RATIOS/PROFITABILITY

  • EPS (TTM)0.00
  • P/E (TTM)10.33
  • Fwd P/E (NTM)-
  • EBITDA (TTM)3.538M
  • ROE (TTM)77.18%
  • Revenue (TTM)24.90M
  • Gross Margin (TTM)49.98%
  • Net Margin (TTM)25.70%
  • Debt To Equity (MRQ)12.01%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Elite Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Elite Pharmaceuticals, Inc. (Elite), is a specialty pharmaceutical company. The Company is principally engaged in the development and manufacture of oral, controlled-release products. The Company develops and manufactures generic products, products using controlled-release drug technology, products utilizing abuse deterrent technologies, and it develops and markets (either on its own or by license to other companies) generic controlled-release and abuse deterrent...
Nasrat Hakim
Chairman
Marc Bregman CPA
Chief Financial Officer
Douglas Plassche
Executive Vice President
Jason LePree Ph.D.
Vice President
Address
165 Ludlow Ave
Northvale, NJ
07647-2305
United States

Top Peers

SYMBOLLASTCHG%CHG
CYTH
Cyclo Therapeutics Inc
4.99+0.19+3.96%
BXRX
Baudax Bio Inc
0.3599+0.0069+1.95%
ACUR
Acura Pharmaceuticals Inc
0.50-0.025-4.7619%
NAVB
Navidea Biopharmaceuticals Inc
1.21+0.01+0.83%
EVOK
Evoke Pharma Inc
0.6821-0.0578-7.8119%
AGRX
Agile Therapeutics Inc
0.60-0.0366-5.7493%